Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ELOA2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA559389
Description
Immunogen sequence: GHKSSRQEKR PLCAQGDWHS PTLIREKSCG ACLREETPRM PSWASARDRQ PSDFKTDKEG GQAGSGQRVP ALEEAPDSHQ Highest antigen sequence identity to the following orthologs: Mouse - 38%, Rat - 41%.
This gene encodes the transcriptionally active subunit of the SIII (or elongin) transcription elongation factor complex, which also includes two regulatory subunits, elongins B and C. This complex acts to increase the rate of RNA chain elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites along the DNA template. Whereas a related protein with similar function, elongin A, is ubiquitously expressed, the encoded protein is specifically expressed in the testis, suggesting it may have a role in spermatogenesis.
Specifications
ELOA2 | |
Polyclonal | |
Unconjugated | |
ELOA2 | |
EloA2; Elongin-A2; HsT832; RNA polymerase II transcription factor SIII subunit A2; TCEB3B; TCEB3L; transcription elongation factor (SIII) elongin A2 elongin A2; transcription elongation factor B polypeptide 3B; transcription elongation factor B subunit 3B | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
51224 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q8IYF1 | |
ELOA2 | |
Recombinant protein corresponding to Human ELOA2. Recombinant protein control fragment (Product #RP-98287). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction